Marketing Or Manufacturing-monoclonal Antibodies
I'm an independent biopharma business researcher looking to speak with folks who have an expertise in either marketing or manufacturing of biologic therapeutics, specifically monoclonal antibodies (mabs). Ideally, these folks would be knowledgeable on companies such as eli lilly, amgen and teva. The ideal person may be someone within these companies or a consultant with this specialty. +undefined Other Responses
We are looking for experts in "minibinder therapeutics" to provide commentary and insights towards a startup that rapidly and efficiently optimizes synthetic biotherapies that are easy to manufacture, shelf stable, and outperform known antibodies.
We are an angel investing platform dedicated to connecting deep-tech startups with angel investors. By deep-tech we mean startups founded on scientific breakthroughs and technological innovations that create lasting impact on mankind.
As a participating expert* in this process, your involvement is limited to answering anywhere between 8-12 investor-submitted questions. This takes about 1 hour (+/-) . Once you are vetted, we send those questions via a web form for your responses. If your contribution is published, it will be viewable by potential investors in this startup, giving you an opportunity to make connections, socialize virtually, and gain bragging rights in a vibrant entrepreneurial and angel investing community.
*at this point, we cannot guarantee any monetary reimbursement. You do get insights to new upcoming technologies in your field and a tremendous networking opportunity!+undefined Other Responses
Indian Generic Drugs Space
We are a global consulting firm currently working on a mandate in the indian generic drugs space.
We are looking to connect with experts having extensive prior experience in the strategy, commercial and r&d functions of indian generic manufacturers with presence in usa retail market and having own api manufacturing setup.
Experience/knowledge of the following topics:
- emerging and high growth areas (therapeutic areas or api product type) in the api space in india and other emerging markets, the us and european market.
- capabilities required to succeed in specific markets and specific therapeutic areas.
- overview on key players in api generics space and various business models adopted by large, midsize and small players (e.G., api focus with formulation add-on's, therapeutic area focus).
Please respond with your relevance to this request and your availability for a paid phone consultation this week.+undefined Other Responses